Changing epidemiology, global trends and implications for outcomes of NAFLD-Reference-Cited by-同舟云学术

Changing epidemiology, global trends and implications for outcomes of NAFLD

Published:2023-09 Issue:3 Volume:79 Page:842-852
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Wong Vincent Wai-Sun^ORCID,Ekstedt Mattias^ORCID,Wong Grace Lai-Hung^ORCID,Hagström Hannes

Funder

Vetenskapsrådet

Chinese University of Hong Kong

Publisher

Elsevier BV

Subject

Hepatology

Reference129 articles.

1. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a systematic review;Younossi;Hepatology,2023

2. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer;Huang;Cell Metab,2022

3. Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States;Younossi;Clin Gastroenterol Hepatol,2021

4. Nash up, virus down: how the waiting list is changing for liver transplantation: a single center experience from Italy;Ferrarese;Medicina (Kaunas),2022

5. Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries;Holmer;Liver Int,2018

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies;Metabolism;2024-12

2. Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers;Metabolism;2024-11

3. Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine;The Journal of Nutritional Biochemistry;2024-11

4. The mechanistic study of diacylglycerol in ameliorating non-alcoholic fatty liver and systemic lipid accumulation;Journal of Functional Foods;2024-10

5. Kurarinol restrains non-alcoholic fatty liver disease-associated hepatocellular carcinoma (HCC) progression by suppressing EGFR signaling;Journal of Functional Foods;2024-10